Sheri Dodd
Vermögen: 2 Mio $ am 31.05.2026
Vermögen: 2 Mio $ am 31.05.2026
Sheri L.
Dodd is Chief Executive Officer & Director at Tactile Systems Technology, Inc. since 2024.
Former roles include Vice President-Health Economics & Reimbursement at Johnson & Johnson from 1997 to 2010, Project Manager at World Health Organization (United States) from 1988 to 1993, VP & GM-Medtronic Care Management Services at Medtronic Plc from 2018 to 2022, and President at Medtronic Canada ULC.
Education includes graduate degrees from London School of Hygiene & Tropical Medicine and London School of Economics & Political Science, and an undergraduate degree from The College of Idaho, Inc.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 09.03.2026 | 79 911 ( 0,35 % ) | 2 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| TACTILE SYSTEMS TECHNOLOGY, INC. | Vorstandsvorsitzender | 01.07.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
| MEDTRONIC PLC | Corporate Officer/Principal | 01.11.2022 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01.03.2010 |
World Health Organization (United States)
World Health Organization (United States) Medical/Nursing ServicesHealth Services The World Health Organization (United States) operates a platform featuring health-focused articles by H. Sandra Chevalier-Batik, emphasizing critical public health topics such as women’s health and vaccine safety. The private company is based in Washington, DC. The platform addresses issues including FDA warnings on certain asthma drugs, calls for independent scientific inquiry into HPV vaccine safety, FDA approvals of vaccines for the 2009 H1N1 influenza virus, and advisory panel recommendations expanding the use of Merck’s Gardasil vaccine. It covers subjects like HPV vaccination, cervical cancer, drug approvals, and vaccine safety, encouraging engagement and awareness in health advocacy with a focus on evaluating pharmaceutical approvals and vaccination policies affecting women’s health. | Corporate Officer/Principal | 01.09.1993 |
Medtronic Canada ULC
Medtronic Canada ULC Medical SpecialtiesHealth Technology Manufactures medical devices | Präsident | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 8 |
|---|---|
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Tactile Systems Technology, Inc.
Tactile Systems Technology, Inc. Medical SpecialtiesHealth Technology Develops and markets medical devices | Health Technology |
London School of Hygiene & Tropical Medicine
London School of Hygiene & Tropical Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
London School of Economics & Political Science
London School of Economics & Political Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medtronic Canada ULC
Medtronic Canada ULC Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
The College of Idaho, Inc.
The College of Idaho, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medtronic Plc
Medtronic Plc Medical SpecialtiesHealth Technology Provides medical technology services | Health Technology |
World Health Organization (United States)
World Health Organization (United States) Medical/Nursing ServicesHealth Services The World Health Organization (United States) operates a platform featuring health-focused articles by H. Sandra Chevalier-Batik, emphasizing critical public health topics such as women’s health and vaccine safety. The private company is based in Washington, DC. The platform addresses issues including FDA warnings on certain asthma drugs, calls for independent scientific inquiry into HPV vaccine safety, FDA approvals of vaccines for the 2009 H1N1 influenza virus, and advisory panel recommendations expanding the use of Merck’s Gardasil vaccine. It covers subjects like HPV vaccination, cervical cancer, drug approvals, and vaccine safety, encouraging engagement and awareness in health advocacy with a focus on evaluating pharmaceutical approvals and vaccination policies affecting women’s health. | Health Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen